P3 Health Partners Inc (NASDAQ:PIII) has a beta value of 1.12 and has seen 1.21 million shares traded in the last trading session. The company, currently valued at $55.34M, closed the last trade at $0.34 per share which meant it gained $0.02 on the day or 8.23% during that session. The PIII stock price is -423.53% off its 52-week high price of $1.78 and 11.76% above the 52-week low of $0.30. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.71 million shares traded. The 3-month trading volume is 448.10K shares.
The consensus among analysts is that P3 Health Partners Inc (PIII) is Buy stock at the moment, with a recommendation rating of 1.80. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.04.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
P3 Health Partners Inc (NASDAQ:PIII) trade information
Sporting 8.23% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PIII stock price touched $0.34 or saw a rise of 10.5%. Year-to-date, P3 Health Partners Inc shares have moved -75.74%, while the 5-day performance has seen it change -5.47%. Over the past 30 days, the shares of P3 Health Partners Inc (NASDAQ:PIII) have changed -31.42%. Short interest in the company has seen 1.08 million shares shorted with days to cover at 1.59.
P3 Health Partners Inc (PIII) estimates and forecasts
Figures show that P3 Health Partners Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -27.51% over the past 6 months, with this year growth rate of 63.49%, compared to 23.90% for the industry. Revenue growth from the last financial year stood is estimated to be 20.40%.
5 analysts offering their estimates for the company have set an average revenue estimate of 364.45M for the current quarter. 5 have an estimated revenue figure of 392.11M for the next ending quarter.
PIII Dividends
P3 Health Partners Inc is expected to release its next earnings report in November this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
P3 Health Partners Inc (NASDAQ:PIII)’s Major holders
Insiders own 23.36% of the company shares, while shares held by institutions stand at 23.63% with a share float percentage of 30.83%. Investors are also buoyed by the number of investors in a company, with P3 Health Partners Inc having a total of 68.0 institutions that hold shares in the company. The top two institutional holders are ALYESKA INVESTMENT GROUP, L.P. with over 15.95 million shares worth more than $7.18 million. As of 2024-06-30, ALYESKA INVESTMENT GROUP, L.P. held 13.4152% of shares outstanding.
The other major institutional holder is ARMISTICE CAPITAL, LLC, with the holding of over 7.9 million shares as of 2024-06-30. The firm’s total holdings are worth over $3.56 million and represent 6.645% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Columbia Acorn Fund and Vanguard Total Stock Market Index Fund . As of Jun 30, 2024 , the former fund manager holds about 3.28% shares in the company for having 5.31 shares of worth $1.82 million while later fund manager owns 1.45 shares of worth $0.5 million as of Jun 30, 2024 , which makes it owner of about 0.90% of company’s outstanding stock.
